RxDoctor Payments DataLook up a doctor →

Colin Barker, MD

Interventional Cardiology · Nashville, TNNPI 1851551238

Payments from drug & device makers

$2,125,312in general payments, 2019–2025

Across 681 payments — averaging $3120.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1.6M
  • Medtronic$162K
  • Boston Scientific$149K
  • Abbott$114K
  • Chiesi USA, Inc.$34K
  • Heartflow, Inc.$28K
  • plus $37K from 16 others
$6,500in research payments, 2019–2025

Across 1 payment — averaging $6500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$7K

What the payments were for

  • Consulting fees$94,37544%
  • Speaking & faculty fees$61,10528%
  • Grants$2220%
  • Travel & lodging$38,23418%
  • Food & beverage$22,88411%
  • Education$10%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,125,312 in reported general payments places this provider in the 95th percentile of 207 interventional cardiology providers in Tennessee.

See all interventional cardiology providers in Tennessee

Medicare billing

Part B allowed, 2024
$184,757
Medicare patients
407
Services billed
912

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$63,070
Repatha SureclickEvolocumab25$21,430
Atorvastatin Calcium49$630
Carvedilol33$395
Metoprolol Succinate23$293
ClopidogrelClopidogrel Bisulfate18$267
Spironolactone25$222
Amlodipine Besylate16$163
Lisinopril36$151
Warfarin Sodium12$124
Rosuvastatin Calcium17$99
Nitroglycerin11$85
Furosemide15$71
Isosorbide Mononitrate ErIsosorbide Mononitrate11$58
Losartan Potassium12$40

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →